Evidence map›Paper›PMID 29069445›Full record

ArticleNucleic acids research2018

TCSBN: a database of tissue and cancer specific biological networks.

Sunjae Lee, Cheng Zhang, Muhammad Arif, Zhengtao Liu, Rui Benfeitas, Gholamreza Bidkhori, Sumit Deshmukh, Mohamed Al Shobky, Alen Lovric, Jan Boren and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Longitudinal big biological data in the AI era.Molecular systems biology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Current State of "Omics" Biomarkers in Pancreatic Cancer.Journal of personalized medicine · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Sunjae LeeScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Cheng ZhangScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Muhammad ArifScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Zhengtao LiuScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Rui BenfeitasScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Gholamreza BidkhoriScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Sumit DeshmukhScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Mohamed Al ShobkyScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Alen LovricScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Jan BorenDepartment of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, SE-413 45, Sweden.
Jens NielsenScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Mathias UhlenScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Adil MardinogluScience for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, SE-171 21, Sweden.
Science for Life Laboratory · SESahlgrenska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biological networks provide new opportunities for understanding the cellular biology in both health and disease states. We generated tissue specific integrated networks (INs) for liver, muscle and adipose tissues by integrating metabolic, regulatory and protein-protein interaction networks. We also generated human co-expression networks (CNs) for 46 normal tissues and 17 cancers to explore the functional relationships between genes as well as their relationships with biological functions, and investigate the overlap between functional and physical interactions provided by CNs and INs, respectively. These networks can be employed in the analysis of omics data, provide detailed insight into disease mechanisms by identifying the key biological components and eventually can be used in the development of efficient treatment strategies. Moreover, comparative analysis of the networks may allow for the identification of tissue-specific targets that can be used in the development of drugs with the minimum toxic effect to other human tissues. These context-specific INs and CNs are presented in an interactive website http://inetmodels.com without any limitation.

Indexed as

Databases, FactualAdipose TissueDatabases, GeneticGene Regulatory NetworksHumansLiverMetabolic Networks and PathwaysMusclesNeoplasmsProtein Interaction MapsSystems BiologyTissue Distribution

Identifiers

PMID29069445
PMCPMC5753183
OpenAlexW2765910974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.